ALK Positive shared on LinkedIn:
“Dr. Christine Lovly, Division Chief, Thoracic Medical Oncology, City of Hope National Medical Center, is on the front lines of treatment for people with ALK+ lung cancer, working hard to propel the field forward and create better outcomes for patients.
My dream is world where ALK+ lung cancer is treatable, then curable, then preventable! – Christine Lovly
She is a leading authority on why tumors become resistant to targeted therapies, research supported by ALK+ Positive. Her dream reaches past a cure to a world where no one has to endure this disease.
Thank you, Dr. Lovly, on everything you’re doing to make our dream of a cure possible.”
Other articles about Christine Lovly on OncoDaily.